NO874159L - Nye lymfokin-relaterte peptider. - Google Patents

Nye lymfokin-relaterte peptider.

Info

Publication number: NO874159L
Authority: NO; Norway
Prior art keywords: related peptides; new lymphokine; lymphokine; new; peptides
Prior art date: 1986-10-03

Application number

NO874159A

Other languages

English (en)

Norwegian (no)

Other versions

NO874159D0 (no

Inventor

Karel Gerrit Odnik

Roger Clerec

Nico Cerletti

Josef Brueggen

Lajos Tarcsay

Clemens Sorg

Walter Wiesendanger

Original Assignee

Ciba Geigy Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-10-03

Filing date

1987-10-02

Publication date

1988-04-05

1986-10-03 Priority claimed from GB868623850A external-priority patent/GB8623850D0/en

1986-11-27 Priority claimed from GB868628358A external-priority patent/GB8628358D0/en

1987-10-02 Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag

1987-10-02 Publication of NO874159D0 publication Critical patent/NO874159D0/no

1988-04-05 Publication of NO874159L publication Critical patent/NO874159L/no

1992-03-17 Priority to NO921024A priority Critical patent/NO921024D0/no

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
- C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/55—Vector systems having a special element relevant for transcription from bacteria
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/70—Vector systems having a special element relevant for transcription from fungi
- C12N2830/702—Vector systems having a special element relevant for transcription from fungi yeast

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Genetics & Genomics (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Medicinal Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Wood Science & Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
Physics & Mathematics (AREA)
Immunology (AREA)
Microbiology (AREA)
Plant Pathology (AREA)
Toxicology (AREA)
Gastroenterology & Hepatology (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Rheumatology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Pain & Pain Management (AREA)
Veterinary Medicine (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Investigating Or Analysing Biological Materials (AREA)
Saccharide Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO874159A 1986-10-03 1987-10-02 Nye lymfokin-relaterte peptider. NO874159L (no)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
NO921024A NO921024D0 (no)	1986-10-03	1992-03-17	Nye lymfokin-relaterte peptider

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB868623850A GB8623850D0 (en)	1986-10-03	1986-10-03	Lymphokine related peptide
GB868628358A GB8628358D0 (en)	1986-11-27	1986-11-27	Lymphokine related peptides

Publications (2)

Publication Number	Publication Date
NO874159D0 NO874159D0 (no)	1987-10-02
NO874159L true NO874159L (no)	1988-04-05

Family

ID=26291377

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO874159A NO874159L (no)	1986-10-03	1987-10-02	Nye lymfokin-relaterte peptider.

Country Status (11)

Country	Link
US (2)	US5350687A (fr)
EP (1)	EP0263072B1 (fr)
JP (1)	JPH09188698A (fr)
AU (1)	AU7930987A (fr)
DE (1)	DE3789413T2 (fr)
DK (1)	DK517787A (fr)
ES (1)	ES2052602T3 (fr)
FI (1)	FI874287L (fr)
IE (1)	IE61773B1 (fr)
NO (1)	NO874159L (fr)
PT (1)	PT85849B (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2750604B1 (fr) *	1996-07-02	2002-09-20	Oreal	Heteromere liant l'acide arachidonique et son utilisation en cosmetique ou pharmacie
WO1990011301A1 (fr) *	1989-03-17	1990-10-04	Genetics Institute, Inc.	Facteur d'inhibition de migration de macrophages humains
GB8915414D0 (en) *	1989-07-05	1989-08-23	Ciba Geigy	Novel cytokines
JP2747839B2 (ja) *	1989-08-14	1998-05-06	花王株式会社	モノクローナル抗体
US5149544A (en) *	1989-11-13	1992-09-22	Research Corporation Technologies, Inc.	Method of inhibiting progenitor cell proliferation
ATE228164T1 (de) *	1990-09-05	2002-12-15	Heart Res Inst Ltd	Chemotaktische faktoren
CH685959A5 (de) *	1992-08-24	1995-11-15	Biomedicals Ag	Diagnostische Testpackung zur Bestimmung von Proteinen.
US6645493B1 (en) *	1993-05-17	2003-11-11	The Picower Institute For Medical Research	Composition containing anti-MIF antibody
US5776348A (en) *	1995-02-07	1998-07-07	Massachusetts Institute Of Technology	Mineral precipitation system and method for inhibiting mineral precipitate formation
EP0972022A2 (fr)	1997-01-21	2000-01-19	Human Genome Sciences, Inc.	Polynucleotides et polypeptides codant des recepteurs
WO2000018970A1 (fr)	1998-09-29	2000-04-06	Asahi Kasei Kabushiki Kaisha	Procede de commande de liberation de granules
WO2000026668A2 (fr) *	1998-11-05	2000-05-11	The Regents Of The University Of Michigan	Proteines s100 et auto-anticorps comme marqueurs seriques pour le cancer
UY27304A1 (es)	2001-05-24	2002-12-31	Avanir Pharmaceuticals	Inhibidores del factor inhibidor de la migración de los macrófagos y métodos para su identificación
AU2003212246A1 (en) *	2002-02-15	2003-09-04	Johannes Roth	Method for diagnosis of inflammatory diseases using mrp8/mrp14
US7553488B2 (en)	2002-07-05	2009-06-30	UNIVERSITé LAVAL	Antibodies against S100A8 and S100A9 proteins for modulating inflammatory reactions
TW200418829A (en)	2003-02-14	2004-10-01	Avanir Pharmaceutics	Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
US7361474B2 (en) *	2003-02-24	2008-04-22	United States Of America As Represented By The Department Of Veterans Affairs	Serum macrophage migration inhibitory factor (MIF) as marker for prostate cancer
EP1608397B1 (fr)	2003-03-28	2008-10-15	Universite Laval	Proteine s100 utilisee en tant qu'activateur des neutrophiles pour attenuer la neutropenie dans le traitement du cancer
CN1839133A (zh) *	2003-08-22	2006-09-27	阿文尼尔药品公司	作为巨噬细胞移动抑制因子的抑制剂的取代的二氮杂萘衍生物及其在治疗人类疾病中的应用
AU2005216236A1 (en) *	2004-02-25	2005-09-09	The United States Of America As Represented By The Department Of Veterans Affairs	Methods for diagnosing and treating bladder cancer
SE0400886D0 (sv) *	2004-04-02	2004-04-02	Amersham Biosciences Ab	Process of purification
CA2573596A1 (fr) *	2004-07-13	2006-01-19	Universite Laval	Inhibiteurs de la proteine s100 utilises pour le traitement la leucemie
US7659087B2 (en) *	2004-07-23	2010-02-09	Aspenbio Pharma, Inc.	Methods and devices for diagnosis of appendicitis
ATE494391T1 (de) *	2004-07-23	2011-01-15	Aspenbio Pharma Inc	Verfahren und vorrichtungen zur diagnose von appendizitis
WO2006102191A1 (fr) *	2005-03-24	2006-09-28	Avanir Pharmaceuticals	Derives de thienopyridinone utilises en tant qu'inhibiteurs du facteur d'inhibition de la migration des macrophages
GB0605689D0 (en) *	2006-03-21	2006-05-03	Novartis Ag	Organic compounds
EP3075867B1 (fr) *	2008-09-03	2019-03-13	Quantumdx Group Limited	Stratégies de détection et procédés destinés à la détection d'acides nucléiques au moyen de biocapteurs
EP2711682B1 (fr)	2011-05-20	2019-07-10	Riken	Réactif de clarification pour des matières biologiques et son utilisation
US9958456B2 (en)	2011-10-07	2018-05-01	Baxalta Incorporated	OxMIF as a diagnostic marker
US10626166B2 (en) *	2014-08-22	2020-04-21	Baxalta Incorporated	Detection of CHO-MIF contaminations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE230876C (fr) *
US4322274A (en) *	1980-08-28	1982-03-30	Wilson Gregory B	Method of diagnosing cystic fibrosis patients and asymptomatic carrier of the cystic fibrosis gene
GB2125047B (en)	1982-08-09	1986-02-19	Ciba Geigy Ag	Yeast hybrid vectors and their use for the production of polypeptides
GB8318754D0 (en) *	1983-07-11	1983-08-10	Fagerhol M K F	Human proteins anti-sera test kits
JPS6041697A (ja) *	1983-08-15	1985-03-05	Asahi Chem Ind Co Ltd	活性蛋白質誘導体の新規合成法
DE3479520D1 (en)	1983-11-21	1989-09-28	Ciba Geigy Ag	Synthesis of tissue plasminogen activator(tpa) by yeast
CA1297437C (fr)	1983-11-21	1992-03-17	Hans Rink	Processus de preparation d'inhibiteurs de protease
JPH0672158B2 (ja)	1984-05-24	1994-09-14	チバ−ガイギ− アクチエンゲゼルシヤフト	精製されたヒトマクロファージ遊走阻止因子
GB8915414D0 (en) *	1989-07-05	1989-08-23	Ciba Geigy	Novel cytokines

1987
- 1987-09-28 ES ES87810561T patent/ES2052602T3/es not_active Expired - Lifetime
- 1987-09-28 DE DE3789413T patent/DE3789413T2/de not_active Expired - Fee Related
- 1987-09-28 EP EP87810561A patent/EP0263072B1/fr not_active Expired - Lifetime
- 1987-09-30 FI FI874287A patent/FI874287L/fi not_active IP Right Cessation
- 1987-10-01 PT PT85849A patent/PT85849B/pt not_active IP Right Cessation
- 1987-10-02 NO NO874159A patent/NO874159L/no unknown
- 1987-10-02 IE IE264587A patent/IE61773B1/en not_active IP Right Cessation
- 1987-10-02 AU AU79309/87A patent/AU7930987A/en not_active Abandoned
- 1987-10-02 DK DK517787A patent/DK517787A/da not_active Application Discontinuation
1990
- 1990-11-21 US US07/617,485 patent/US5350687A/en not_active Expired - Fee Related
1995
- 1995-07-27 US US08/508,142 patent/US5702920A/en not_active Expired - Fee Related
1996
- 1996-12-18 JP JP8338746A patent/JPH09188698A/ja active Pending

Also Published As

Publication number	Publication date
DK517787D0 (da)	1987-10-02
IE872645L (en)	1988-04-03
DE3789413D1 (de)	1994-04-28
US5350687A (en)	1994-09-27
US5702920A (en)	1997-12-30
IE61773B1 (en)	1994-11-30
EP0263072B1 (fr)	1994-03-23
PT85849A (en)	1987-11-01
FI874287A0 (fi)	1987-09-30
FI874287A7 (fi)	1988-04-04
EP0263072A2 (fr)	1988-04-06
DE3789413T2 (de)	1994-07-28
EP0263072A3 (en)	1990-01-10
AU7930987A (en)	1988-05-19
JPH09188698A (ja)	1997-07-22
PT85849B (pt)	1990-07-31
ES2052602T3 (es)	1994-07-16
NO874159D0 (no)	1987-10-02
DK517787A (da)	1988-04-04
FI874287L (fi)	1988-04-04

Publication	Publication Date	Title
NO874159D0 (no)	1987-10-02	Nye lymfokin-relaterte peptider.
FI873185A7 (fi)	1988-01-22	Uusia peptidejä.
NO894919D0 (no)	1989-12-07	Nye aminobenzoater.
FI861007A7 (fi)	1986-09-13	Uusia peptidejä.
NO864237D0 (no)	1986-10-23	Nye forbindelser.
FI873581A0 (fi)	1987-08-19	Fast stoedanordning.
FI865346A7 (fi)	1987-07-11	Naeringstillfoerselsystem foer central naeringstillfoersel.
NO872590D0 (no)	1987-06-19	Nye kompleksforbindelser.
NO881384D0 (no)	1988-03-29	Peptider.
NO885108L (no)	1989-05-18	Peptider.
FI883257A7 (fi)	1988-07-07	Uudet peptidit.
NO862922D0 (no)	1986-07-21	Nye forbindelser.
NO894907L (no)	1990-06-11	Nye alfa-cyano-beta-oksopropionamider.
NO892949L (no)	1990-01-22	Nye proteiner.
NO882886L (no)	1989-01-02	Nye forbindelser.
NO883818D0 (no)	1988-08-26	Nye forbindelser.
NO904319L (no)	1991-04-08	Nye forbindelser.
NO891403D0 (no)	1989-04-04	Nye forbindelser.
NO901032L (no)	1990-09-10	Nye forbindelser.
NO872386D0 (no)	1987-06-05	Peptider.
NO883021D0 (no)	1988-07-06	Nye peptider.
NO874091L (no)	1987-09-29	Nye trombolytiske proteiner.
NO912122D0 (no)	1991-06-03	Nye allylaminoetylazoler.
NO874734L (no)	1987-11-12	Nye peptidderivater.
FI875151A7 (fi)	1987-11-20	Uudet peptidijohdannaiset.